Updated: February 19, 2026
How to Help Your Patients Find Oxandrolone in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
- First: Confirm Your Practice Is Set Up to Prescribe Compounded Controlled Substances
- Establish a Relationship With a Reliable Compounding Pharmacy
- Writing the Prescription: What to Include
- Counseling Patients on What to Expect
- If Your Patient Can't Find a Pharmacy: Use medfinder
- When to Consider an Alternative Instead
Oxandrolone is only available via compounding pharmacies after the 2023 FDA withdrawal. This practical guide helps providers navigate the compounding pathway for their patients.
Since the FDA's June 2023 withdrawal of commercial oxandrolone from the US market, many providers have found their patients struggling to fill oxandrolone prescriptions. The standard advice — call a pharmacy — no longer applies in the same way. This guide gives you practical steps to help your patients navigate the compounding pharmacy pathway in 2026.
First: Confirm Your Practice Is Set Up to Prescribe Compounded Controlled Substances
Before prescribing compounded oxandrolone, ensure the following are in place in your practice:
- Current DEA registration: Oxandrolone is Schedule III. Verify your DEA registration includes Schedule III authority and is current.
- State-specific prescribing rules: Some states have additional restrictions on prescribing compounded controlled substances. Confirm your state medical board's requirements.
- Documentation practice: Document the clinical indication, the fact that commercial oxandrolone is unavailable, and that the patient has been informed that the compounded product is not FDA-approved.
Establish a Relationship With a Reliable Compounding Pharmacy
The most efficient approach is to identify one or two compounding pharmacies ahead of time that can reliably fill oxandrolone. When evaluating pharmacies, look for:
- PCAB accreditation: The Pharmacy Compounding Accreditation Board accreditation signals quality and standardized practices.
- DEA Schedule III license: Confirm they are specifically licensed to compound and dispense Schedule III controlled substances in your patient's state.
- Oxandrolone API inventory: Ask specifically if they currently source and stock oxandrolone active pharmaceutical ingredient (API). Some pharmacies can compound it on request; others may have lead times if they need to order API.
- Multi-state shipping: If you practice in multiple states or have patients who travel, a nationally operating pharmacy simplifies logistics.
Writing the Prescription: What to Include
Compounding pharmacies need more detail than a standard prescription to prepare the medication properly. Include:
- Drug name: oxandrolone
- Dosage form: oral tablet (or capsule if the pharmacy cannot compound tablets)
- Strength: e.g., 2.5 mg, 5 mg, or 10 mg per tablet
- Quantity: e.g., 60 tablets for a 30-day supply at BID dosing
- Directions: e.g., "Take 1 tablet by mouth twice daily for 4 weeks"
- Your DEA number, NPI, name, address, and signature
- Check whether the pharmacy accepts electronic/faxed prescriptions for Schedule III — many require original written prescriptions
Counseling Patients on What to Expect
Patients accustomed to picking up prescriptions same-day at a retail pharmacy will need to adjust expectations:
- Lead time: Compounded medications are made to order. Typical turnaround is 3–7 business days; plan accordingly for ongoing therapy.
- Cost: Most insurance does not cover compounded controlled substances. Out-of-pocket cost is typically $150–$350 per 30-day supply. Patients should request a cost estimate before submitting the prescription.
- Not FDA-approved: The compounded preparation differs from the former commercial product in that it lacks FDA approval and quality review for the specific compounded batch.
- Schedule III rules: Only up to 5 refills within 6 months are permitted. After that, a new prescription is required.
If Your Patient Can't Find a Pharmacy: Use medfinder
Locating the right compounding pharmacy is often the hardest part for patients, especially those in areas with limited compounding options. medfinder for providers contacts pharmacies on your patients' behalf to identify which ones can fill a specific prescription. This reduces calls to your office and helps patients get what they need faster.
When to Consider an Alternative Instead
For patients who face significant cost barriers or live in areas where compounding pharmacy access is limited, consider switching to a therapeutic alternative before the prescription gap becomes a clinical problem. Testosterone therapy (injectable, topical, or oral) is the most broadly accessible alternative for most indications. See our full alternative guide: Alternatives to Oxandrolone if You Can't Fill Your Prescription.
Frequently Asked Questions
Providers with current DEA Schedule III registration can still write prescriptions for oxandrolone. The prescription must be directed to a licensed 503A compounding pharmacy that is also DEA-registered for controlled substance compounding. Most compounding pharmacies will prepare oxandrolone in custom strengths upon receipt of a valid patient-specific prescription.
Document the clinical indication for oxandrolone use, confirmation that commercially available products are no longer available, the patient's informed consent that the compounded product is not FDA-approved, planned monitoring schedule (LFTs, lipid panel, and as clinically indicated), and any discussion of therapeutic alternatives considered and declined.
Telehealth prescribing of Schedule III controlled substances requires compliance with DEA telehealth regulations, which have undergone changes since the pandemic-era waivers expired. As of 2026, prescribing Schedule III controlled substances via telehealth generally requires either an in-person evaluation before the first prescription or use of a DEA-registered telemedicine platform that complies with current special registration rules. Verify current DEA and state requirements before prescribing oxandrolone via telehealth.
Traditional manufacturer patient assistance programs (PAPs) do not apply since there is no commercial manufacturer. Some compounding pharmacies offer payment plans or sliding scale fees for established patients. For patients unable to afford compounded oxandrolone, discuss switching to a therapeutic alternative such as generic testosterone cypionate injections, which are typically covered by insurance and cost under $30/month with insurance.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Oxandrolone also looked for:
More about Oxandrolone
34,034 have already found their meds with Medfinder.
Start your search today.





